 Other References: |
Cook et al; "Drug and Chemical Toxicology"; (1988 Jun.) vol. 11(2), pp. 195-213 (Abstract).
(19 pages)
Public Health Service. Preventing lead poisoning in young children: A statement by the Centers for Disease Control. Atlanta: CDC, 1984.
Bellinger D, Leviton A, Waternaux C, Needleman H, Rabinowitz M. Longitudinal analyses of prenatal and postnatal lead exposure and early cognitive development. N Engl J Med 1987; 316:1037-43.
(7 pages)
Cited by 3 patents
Agency for Toxic Substances and Disease Registry. The nature and extent of lead poisoning in children in the United States: A report to Congress. Atlanta:ATSDR, 1988.
Valentine WN, Fink K, Paglia DE, Harris SR, Adains WS. Hereditary hemolytic anemia with human erythrocyte pyrimidine 5'-nucleotidase deficiency. J Clin Invest 1974; 54:866-79.
(14 pages)
Paglia DE, Valentine WN. Characteristics of a pyrimidine-specific 5'-nucleotidase in human erythrocytes. J Biol Chem 1975; 250: 7973-79.
(7 pages)
Cited by 2 patents
Paglia DE, Valentine WN, Keitt AS, Brockway RA, Nakatani M. Pyrimidine nucleotidase deficiency with active dephosphorylation of dTMP: Evidence for existence of thymidine nucleotidase in human erythrocytes. Blood 1983;62:1147-49.
(3 pages)
Paglia DE, Valentine WN, Brockway RA. Identification of thymidine nucleotidase and deoxyribonucleotidase activities among normal isozymes of 5'-nucleotidase in human erythrocytes. Proc Natl Acad Sci (USA) 1984; 81:588-92.
(5 pages)
Paglia DE, Valentine WN, Brockway RA, Nakatani M. Substrate specificity and pH sensitivity of deoxyribonucleotidase and pyrimidine nucleotidase activities in human hemolysates. Exp Hematol 1987; 15:1041-47.
(7 pages)
Fiske CH, SubbaRow Y. The colorimetric determination of phosphorus. J Biol Chem 1925; 66:375-400.
Paglia DE, Valentine WN. Hereditary and acquired defects in the pyrimidine nucleotidase of human erythrocytes. Current Topics Hematol 1980; 3:75-109.
Paglia DE, Valentine WN, Dahlgren JG. Effects of low-level lead exposure on pyrimidine 5'-nucleotidase and other erythrocyte enzymes. Possible role of pyrimidine 5'-nucleotidase in the pathogenesis of lead-induced anemia. J Clin Invest 1975; 56:1164-69.
(6 pages)
Paglia DE, Valentine WN, Fink K. Lead poisoning. Further observations on erythrocyte pyrimidine-nucleotidase deficiency and intracellular accumulation of pyrimidine nucleotides. J Clin Invest 1977; 60:1362-66.
(5 pages)
Valentine WN, Paglia DE, Fink K, Madokoro G. Lead poisoning: Association with hemolytic anemia, basophilic stippling, erythrocyte pyrimidine 5'-nucleotidase deficiency and intraerythrocytic accumlulation of pyrimidines. J Clin Invest 1976; 58:926-32.
(7 pages)
Buc HA, Kaplan JC. Red-cell pyrimidine 5'-nucleotidase and lead poisoning. Clin Chim Acta 1978; 87:49-55.
(7 pages)
Angle CR, McIntire MS. Low level lead and inhibition of erythrocyte pyrimidine nucleotidase. Environ Res 1978; 17:296-302.
(7 pages)
Brunet M, Vives-Corrons JL, Torra M, Rodamilans M, Pujades A, Corbella J, Pascual A. Assessment of erythrocyte pyrimidine 5'-nucleotidase activity in the detection and early diagnosis of lead poisoning. A comparison with zinc-protoporphyrin. Medicina Clin 1988; 91:521-24.
(4 pages)
Mohammed-Brahim B, Buchet JP, Lauwerys R. Erythrocyte pyrimidine 5'-nucleotidase activity in workers exposed to lead, mercury or cadmium. Int Arch Occup Environ Health 1985; 55:247-255.
(6 pages)
Ichiba M, Tomokuni K. Studies on erythrocyte pyrimidine 5'-nucleotidase (P5N) test and its evaluation in workers occupationally exposed to lead. Int Arch Occup Environ Health 1990; 62:305-10.
(6 pages)
Cook L, Kubitschek C, Stohs S, Angle C. Erythrocyte pyrimidine 5'-nucleotidase and deoxynucleotidase isozymes: metallosensitivity and kinetics. Drug Chem Toxicol 1988; 11:195-213.
(19 pages)
Ichiba M, Tomokuni K, Sugimoto K. Erythrocyte pyrimidine 5'-nucleotidase test for occupational lead exposure. Industr Health 1987; 25:195-213.
(10 pages)
Fell GS. Lead toxicity: problems of definition and laboratory evaluation. Ann Clin Biochem 1984; 21:453-60.
(8 pages)
Mitchell DG, Aldous KM, Ryan FJ. Mass screening for lead poisoning: capillary blood sampling and automated Delves-cup atomic-absorption analysis. N Y State J Med 1974; 74:1599-1603.
(5 pages)
Piomelli S, Graziano J. Laboratory diagnosis of lead poisoning. Ped Clinics NA 1980; 27:843-53.
Wang ST, Pizzolato S, Peter F. Microsampling technique and determination of blood lead by Zeeman atomic absorption spectrophotometry. Sci Total Environ 1988; 71:37-43.
(7 pages)
Jacobson B, Lockitch G, Quigley G. Improved sample preparation for accurate determination of low concentrations of lead in whole blood by graphite furnace analysis. Clin Chem 1991,.37:515-19.
(5 pages)
Cited by 2 patents
[ISI abstract]
McElvaine MD, Orbach HG, Binder S, Blanksma LA, Maes EF, Krieg RM. Evaluation of the erythrocyte protoporphyrin test as a screen for elevated blood lead levels. J Pediatr 1991; 119:548-50.
(3 pages)
Cited by 2 patents
[ISI abstract]
Hemberg S, Nikkanen J, Mellen G, Lilius H. δ-aminolevulinic acid dehydrase as a measure of lead exposure. Arch Envrion Health 1970; 21:140-45.
|
Nominate this for the Gallery...
